Boothbay Fund Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.04M | Buy |
25,244
+19,598
| +347% | +$2.26M | 0.04% | 470 |
|
|
2025
Q4 | $594K | Sell |
5,646
-13,923
| -71% | -$1.31M | 0.01% | 1041 |
|
|
2025
Q3 | $1.64M | Buy |
19,569
+8,064
| +70% | +$664K | 0.02% | 643 |
|
|
2025
Q2 | $911K | Buy |
+11,505
| New | +$915K | 0.02% | 715 |
|
|
2025
Q1 | – | Sell |
-7,905
| Closed | -$786K | – | 1635 |
|
|
2024
Q4 | $786K | Buy |
+7,905
| New | +$815K | 0.02% | 712 |
|
|
2024
Q3 | – | Sell |
-52,426
| Closed | -$6.49M | – | 1811 |
|
|
2024
Q2 | $6.49M | Buy |
52,426
+19,572
| +60% | +$2.52M | 0.15% | 154 |
|
|
2024
Q1 | $4.34M | Sell |
32,854
-181,426
| -85% | -$22.4M | 0.08% | 271 |
|
|
2023
Q4 | $23.4M | Buy |
214,280
+11,638
| +6% | +$1.21M | 0.6% | 15 |
|
|
2023
Q3 | $20.9M | Buy |
202,642
+83,119
| +70% | +$8.96M | 0.5% | 22 |
|
|
2023
Q2 | $13.8M | Sell |
119,523
-101,737
| -46% | -$11.6M | 0.3% | 41 |
|
|
2023
Q1 | $23.5M | Buy |
221,260
+144,419
| +188% | +$15.6M | 0.48% | 16 |
|
|
2022
Q4 | $8.53M | Sell |
76,841
-55,146
| -42% | -$5.64M | 0.2% | 89 |
|
|
2022
Q3 | $11.4M | Buy |
131,987
+53,921
| +69% | +$4.81M | 0.28% | 39 |
|
|
2022
Q2 | $7.12M | Sell |
78,066
-23,299
| -23% | -$2.07M | 0.19% | 91 |
|
|
2022
Q1 | $8.32M | Buy |
101,365
+95,813
| +1,726% | +$7.55M | 0.19% | 98 |
|
|
2021
Q4 | $426K | Buy |
5,552
+1,221
| +28% | +$97.3K | 0.01% | 1085 |
|
|
2021
Q3 | $325K | Sell |
4,331
-28,572
| -87% | -$2.17M | 0.01% | 1290 |
|
|
2021
Q2 | $2.56M | Sell |
32,903
-67,179
| -67% | -$5M | 0.08% | 296 |
|
|
2021
Q1 | $7.36M | Buy |
100,082
+38,167
| +62% | +$2.82M | 0.28% | 62 |
|
|
2020
Q4 | $4.83M | Buy |
61,915
+40,668
| +191% | +$3.11M | 0.18% | 101 |
|
|
2020
Q3 | $1.68M | Buy |
21,247
+16,346
| +334% | +$1.28M | 0.1% | 267 |
|
|
2020
Q2 | $362K | Sell |
4,901
-4,266
| -47% | -$321K | 0.02% | 652 |
|
|
2020
Q1 | $673K | Sell |
9,167
-26,826
| -75% | -$2.11M | 0.06% | 396 |
|
|
2019
Q4 | $3.12M | Buy |
35,993
+3,150
| +10% | +$259K | 0.27% | 84 |
|
|
2019
Q3 | $2.64M | Buy |
+32,843
| New | +$2.63M | 0.24% | 100 |
|
|
2018
Q2 | – | Sell |
-6,444
| Closed | -$364K | – | 839 |
|
|
2018
Q1 | $335K | Buy |
+6,444
| New | +$348K | 0.04% | 430 |
|
|
2017
Q3 | – | Sell |
-4,283
| Closed | -$262K | – | 714 |
|
|
2017
Q2 | $262K | Sell |
4,283
-354
| -8% | -$21.5K | 0.05% | 458 |
|
|
2017
Q1 | $281K | Sell |
4,637
-8,194
| -64% | -$497K | 0.05% | 456 |
|
|
2016
Q4 | $721 | Buy |
12,831
+2,589
| +25% | +$152K | 0.16% | 146 |
|
|
2016
Q3 | $610K | Buy |
+10,242
| New | +$599K | 0.13% | 169 |
|
|
2015
Q3 | – | Sell |
-4,892
| Closed | -$266K | – | 545 |
|
|
2015
Q2 | $266K | Sell |
4,892
-566
| -10% | -$31.7K | 0.11% | 243 |
|
|
2015
Q1 | $299K | Buy |
+5,458
| New | +$309K | 0.2% | 141 |
|
Other funds holding MRK
VCM
VPM
Boothbay Fund Management's MRK Position: Q1 2026 in Review
Boothbay Fund Management increased its Merck (MRK) stake by 347% in Q1 2026, buying an estimated $2.26M and bringing the position to 25,244 shares worth $3.04M. The position accounts for 0.04% of the portfolio, ranked #470.
Boothbay Fund Management first reported a position in MRK in Q1 2015 and has held it in 32 quarters since. The position peaked at $23.5M in Q1 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Boothbay Fund Management held 25,244 shares of Merck worth $3.04M as of Q1 2026.
- Boothbay Fund Management bought 19,598 Merck shares in Q1 2026, an estimated $2.26M.
- Merck made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #470 holding.
- Boothbay Fund Management first reported a position in Merck in Q1 2015 and has held it in 32 quarters since.
- Boothbay Fund Management's Merck position peaked at $23.5M in Q1 2023.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.